On December 16, 2022, Carol L. Brosgart, M.D., notified the board of directors of Mirum Pharmaceuticals, Inc. of her resignation as a director of the Company and as a member of the Nominating and Corporate Governance Committee of the Board, effective December 19, 2022. Following Dr. Brosgart's resignation, she plans to assume a new role as the Company's senior advisor in science and policy.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
24.28 USD | -0.68% | -0.41% | -17.17% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.17% | 115.19Cr | |
+41.90% | 5.81TCr | |
-5.99% | 4.05TCr | |
+37.52% | 3.9TCr | |
+13.15% | 2.67TCr | |
-12.56% | 2.66TCr | |
-21.66% | 1.9TCr | |
-0.32% | 1.22TCr | |
+24.07% | 1.2TCr | |
+24.86% | 1.19TCr |
- Stock Market
- Equities
- MIRM Stock
- News Mirum Pharmaceuticals, Inc.
- Mirum Pharmaceuticals, Inc. Announces Resignation of Carol L. Brosgart, M.D. as A Director of the Company and as A Member of the Nominating and Corporate Governance Committee of the Board, Effective December 19, 2022